MedPath

Percutaneous Plug-based Arteriotomy Closure Device Use in Minimally Invasive Mitral Valve Surgery

Completed
Conditions
Mitral Valve Disease
Interventions
Procedure: Surgical cut-down and arterial puncture under direct vision
Procedure: Percutaneous arteriotomy closed using a plug-based arteriotomy closure device
Registration Number
NCT03697941
Lead Sponsor
Karolinska University Hospital
Brief Summary

A single-center prospective study. Patients undergoing minimally invasive mitral valve surgery between February 2016 and December 2018 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed either with surgical cut-down and arterial puncture under direct vision or percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA, Essential Medical Inc., Malvern, Pennsylvania). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review and from the Swedish Web system for Enhancement and Development of Evidence based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) electronic data collection platform.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
268
Inclusion Criteria
  • Operated with minimally invasive mitral valve surgery between February 2016 and March 2019 at the Karolinska University Hospital in Stockholm, Sweden, with use of either surgical cut-down and arterial puncture under direct vision or percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device.
Exclusion Criteria
  • None.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Surgical cut-down and arterial puncture under direct visionSurgical cut-down and arterial puncture under direct vision-
Percutaneous arteriotomy closed with closure devicePercutaneous arteriotomy closed using a plug-based arteriotomy closure device-
Primary Outcome Measures
NameTimeMethod
Major vascular groin-related complication according to the VARC-2 definition criteriaDuring the first 8 weeks after surgery
Secondary Outcome Measures
NameTimeMethod
Access-site related groin seromaDuring the first 8 weeks after surgery
Access-site related groin infectionDuring the first 8 weeks after surgery
Minor vascular groin-related complication according to the VARC-2 definition criteriaDuring the first 8 weeks after surgery

Trial Locations

Locations (1)

Karolinska University Hospital

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath